{"assertionCriteria": {"method": "ClinGen PAH ACMG Specifications v1", "citation": {"url": "https://submit.ncbi.nlm.nih.gov/ft/byid/i2ra5ppm/clingen_pah_acmg_specifications_v1.pdf"}}, "clinicalSignificance": {"citation": [{"db": "PubMed", "id": "PMID:31623983"}, {"db": "PubMed", "id": "PMID:32106880"}, {"db": "PubMed", "id": "PMID:10394930"}, {"url": "https://erepo.clinicalgenome.org/evrepo/ui/interpretation/fb82abb9-c0f3-4901-acad-0e2a6de4b34d"}], "clinicalSignificanceDescription": "Likely pathogenic", "comment": "The c.716G>T (p.Gly239Val) variant in PAH has been reported in 2 individuals with classic PKU (PMID 10394930, 31623983) detected with pathogenic variants p.R408W and IVS10\u201311g>a (PMID: 32106880). This variant has extremely low frequency in gnomAD (MAF=0.00006). Computational evidence supports a deleterious effect. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PP4, PM2, PM3, PP3.", "dateLastEvaluated": "2020-10-23", "modeOfInheritance": "Autosomal recessive inheritance"}, "conditionSet": {"condition": [{"db": "MONDO", "id": "MONDO:0009861"}]}, "localID": "fb82abb9-c0f3-4901-acad-0e2a6de4b34d", "localKey": "fb82abb9-c0f3-4901-acad-0e2a6de4b34d", "observedIn": [{"collectionMethod": "curation", "alleleOrigin": "germline", "affectedStatus": "unknown", "numberOfIndividuals": 0}], "recordStatus": "novel", "releaseStatus": "public", "variantSet": {"variant": [{"gene": [{"symbol": "PAH"}], "hgvs": "NC_000012.12:g.102852941C>A"}]}}